Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 198 Leukemia, Lymphocytic, Chronic, B-Cell 48 Myelodysplastic Syndromes 39 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Recurrence 27 Leukemia 26 Lymphoma, Mantle-Cell 22 Leukemia, Myelomonocytic, Chronic 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Biphenotypic, Acute 15 Lymphoma, Follicular 14 Lymphoma, Non-Hodgkin 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma 12 Burkitt Lymphoma 12 Lymphoma, B-Cell, Marginal Zone 10 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Neoplasm, Residual 9 Hematologic Neoplasms 9 Multiple Myeloma 7 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Waldenstrom Macroglobulinemia 5 Neoplasms 5 Lymphoma, B-Cell 5 Leukemia, Myeloid 5 Blastic Plasmacytoid Dendritic Cell Neoplasm 5 Leukemia, B-Cell 4 Immunoglobulin Light-chain Amyloidosis 4 Blast Crisis 4

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Neoplasm Female × venetoclax × Clear all

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡